Related Experiment Video
Updated: Jun 21, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
[The role of syntaxin1A/synaptosome-associated protein-25 in reversing hyperglycemia-induced alpha cell toxicity]
Xiao-Xia Shen1, Hong-Liang Li, Jing Hong
1Department of Endocrinology, China Japan Friendship Hospital, Beijing 100029, China.
Objective:
To investigate the effects of reversal of hyperglycemic toxicity on the synthesis and secretion of glucagon by the alpha cells and the possible mechanisms thereof.
Methods:
Mouse glucagonoma cells of the line TC1-6 were cultured in medium containing 5.5 mmol/L glucose for 10 days (low glucose group, LG), in medium containing 25 mmol/L glucose for 10 days (high glucose group, HG), in medium with 25 mmol/L glucose for 5 days and then in medium with 5.5 mmol/L glucose for 5 days (high-low glucose group, HL group), or in medium with 5.5 mmol/L glucose for 5 days and then in medium with 25 mmol/L glucose for 5 days (LH group), Radioimmunoassay was used to detect the glucagon concentration in the supernatant. RT-PCR was used to detect the mRNA expression of glucagon in the TC1-6 cells. Western blotting was used to detect the protein expression of the Snare proteins: syntaxin1A and synaptosome-associated protein (SNAP)-25.
Results:
(1) The glucagon level of the HG/LG group was lower than that of the HG group by 29% (P < 0.05). (2) The glucagon mRNA expression level in the TC1-6 cells of the HG/HL group was significantly lower than that of the HG group by (52.6 +/- 2.8)% (P < 0.05). (3) The syntaxin1A and SNAP-25 expression levels in the TC1-6 cells of the HG group were significantly higher than those of the LG group by 36% and 69% respectively (both P < 0.05), and the syntaxin1A and SNAP-25 expression levels in the TC1-6 cells of the HG/LG group were significantly lower than those of the HG group by 49% and 56% respectively (both P < 0.05).
Conclusion:
After removing the high glucose toxicity the abnormal glucagon secretion by the alpha-cells can be ameliorated obviously, and the expression levels of syntaxin1A and SNAP-25 proteins that promote the secretion of glucagon are reduced accordingly.
Insights
Reversing high glucose toxicity in alpha cells significantly reduces abnormal glucagon secretion. This improvement correlates with decreased expression of syntaxin1A and synaptosome-associated protein (SNAP)-25, key proteins in glucagon release.
Area of Science:
- Endocrinology
- Cell Biology
Background:
- Hyperglycemic toxicity can impair alpha cell function.
- Understanding the mechanisms of glucagon secretion is crucial for metabolic disease research.
Purpose of the Study:
- To investigate the impact of reversing hyperglycemic toxicity on glucagon synthesis and secretion by alpha cells.
- To elucidate the underlying molecular mechanisms, focusing on Snare proteins.
Main Methods:
- Mouse glucagonoma TC1-6 cells were cultured under varying glucose conditions (low, high, high-low, low-high).
- Glucagon levels were measured using radioimmunoassay.
- Glucagon mRNA expression was assessed via RT-PCR.
- Protein expression of syntaxin1A and SNAP-25 was analyzed by Western blotting.
Main Results:
- Reversing high glucose exposure (high-low group) significantly reduced glucagon levels and mRNA expression compared to sustained high glucose.
- High glucose increased syntaxin1A and SNAP-25 protein expression.
- The high-low glucose group showed significantly reduced syntaxin1A and SNAP-25 expression compared to the high glucose group.
Conclusions:
- Reversal of high glucose toxicity ameliorates abnormal glucagon secretion from alpha cells.
- Reduced expression of syntaxin1A and SNAP-25 is associated with improved glucagon secretion following glucose toxicity reversal.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Glucose Absorption Into the Small Intestine

